Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Dubai Derma: 'Psoriasis is a Serious Global Problem'


News provided by

Dubai Derma

07 Jul, 2021, 14:46 GMT

Share this article

Share toX

Share this article

Share toX

WHO: Psoriasis Prevalence Ranges between 0.09% and 11.43%

At Least 100 Million Individuals Affected Worldwide

DUBAI, UAE, July 7, 2021 /PRNewswire/ -- The activities of the 20th edition of Dubai World Dermatology and Laser Conference & Exhibition 'Dubai Derma' continue, as visitors and attendees agree to the monumental success of this edition of the event. This year, 'Dubai Derma' features a rich scientific agenda that highlights the most pressing topics in the field, in addition to the rich exhibition which features some of the most prominent international companies in the field of dermatology, cosmetic surgery, and Lasers.

Continue Reading
This image opens in the lightbox
Dubai Derma 2021 conference

Furthermore, the 20th edition of 'Dubai Derma' is held physically in Dubai, with the participation of more than 350 exhibiting companies representing more than 500 international brands, over 180 world-renowned speakers who are participating in more than 200 scientific lectures and workshops. The convening of 'Dubai Derma' physically and in-person is a testament of Dubai's pioneering position as one of the most ideal cities in the world for hosting conferences, exhibitions and world class events, while ensuring the safety and protection of visitors and participants alike. Moreover, participants expressed their gratitude for the precautionary measures provided by the Emirate of Dubai and implemented by the Dubai World Trade Center, which ensures their safety, and their application of the highest international standards to guarantee the safety of participants, visitors and organizers alike.

The second day of 'Dubai Derma' conference highlighted some key topics such as: Nail Disease, Chronic Hand Eczema, treatment of scars, Management of Melasma, Resistant Acne, Androgenic Alopecia, and many others.

One of the lectures that received a great response from attendees was a lecture presented by Dr. Ashraf Reda, Consultant Dermatologist in Welcare Hospital, Adjunct Clinical Associate Professor of Dermatology, Mohamed Bin Rashed University, College of Medicine, Dubai, where he spoke about Urticaria and conditions related to it.

In addition, Dr. Reda confirmed that Dubai Derma is an exceptional platform that provides the latest scientific information and innovations in the field of dermatology, medications, skincare and lasers. He commented saying: "the goal of the conference is enabling dermatologists in the UAE and the world to offer the best possible care to their patients. In order to achieve this goal, dermatologists need to keep themselves abreast with the most up to date information and continuous sophisticated education.  Currently, the field of dermatology is in the midst of great transformation and the most remarkable advances in the past few years have occurred in the field of biologics and other new medications which  treat many chronic and difficult diseases such as 'psoriasis' and 'atopic dermatitis' to name a few".

From his side, Dr. Samir Hantirah, Consultant Dermatologist, American Hospital-Dubai, Fellow of the American Academy of Dermatology (AAD), Fellow of the American Society of Cosmetic Dermatology & Aesthetic Surgery also mentioned that according to the World Health Organization 'WHO', the reported prevalence of Psoriasis in countries ranges between 0.09% and 11.43%, making Psoriasis a serious global problem with at least 100 million individuals affected worldwide.

He added: "Plaque Psoriasis is one of the most common forms which causes dry, raised, red skin patches (lesions) covered with silvery scales. Despite being a chronic disease with no cure, due to development and new updates in treatment, there is now a new medicine available called "IL-23 inhibitor" for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy."

Whereas Mohammad Aboubakr, AbbVie Gulf General Manager, expressed his pride participating in such a great conference which emerged as the largest scientific skincare gathering of consultants and specialist dermatologists in the Middle East, North Africa & the Indian Subcontinent region. Over the years, Dubai Derma was constantly held under the theme "Skin Health is our Concern" bringing together skincare specialists, industry leaders, and key decision-makers from the region and across the world.

He added: "The scientific program of Dubai Derma was well constructed with great lectures on the most trending topics in skin health like New Diagnostic Tools and Treatment Modalities, Management of Psoriasis in adults, Fillers and Rheology, Chronic Hand Eczema with the aim of exploring new advances in treatments for various skin disorders.

He concluded: "we at AbbVie believe in the great responsibility towards increasing patients' awareness towards dealing with various skin diseases, in our constant research and development efforts and work for the best treatments that contribute to alleviating the suffering of patients."

Furthermore, the dynamic 'Dubai Derma' exhibition featured the latest technologies, products, and machines, and facilitated countless collaboration and networking opportunities for exhibitors and visitors alike. The exhibition area attracted a large number of attendees who were able to experience the products showcased first-hand, and were introduced to the latest innovations by international companies and brands.

Moreover, the second day of 'Dubai Derma' featured various digital poster presentations, where researchers were given the chance to present their research and engage in conversations regarding the topics of their presentations with the scientific committee of the event.

Dubai Derma is supported by the Pan Arab League of Dermatology, Arab Academy of Dermatology & Aesthetics (AADA), and GCC League of Dermatologists and with the support of the Government of Dubai and Dubai Health Authority (DHA), and Dubai Business Events, Dubai Derma's destination partner. Furthermore, the event is also supported by the American Academy of Dermatology, Cosmetic Dermatology Society of India, the European Academy of Dermatology and Venereology, Egyptian Society of Plastic and Reconstructive Surgeons (ESPRS), Indian Association of Dermatologists, Venereologists and Leprologists (IADVL), Pakistan Association of Dermatologists, and Sri Lanka College of Dermatologists.

Dubai Derma is annually organized by INDEX Conferences and Exhibitions, a member of INDEX Holding, in cooperation with the Arab Academy of Dermatology and Aesthetics (AADA).

Contact:
Public: Nada Saaydeh
nada.saaydeh@index.ae
+971 50 155 6519

Photo - https://mma.prnewswire.com/media/1559314/Dubai_Derma.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.